This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsSproutly Canada (SPR) 주식 개요는 수용성 대마초 용액과 바이오 천연 오일을 생산하여 캐나다의 음료 및 소모품 시장에 공급하는 회사입니다. 자세히 보기SPR 펀더멘털 분석스노우플레이크 점수가치 평가0/6미래 성장0/6과거 실적0/6재무 건전성0/6배당0/6위험 분석의미 있는 시가총액이 없습니다(CA$8M)주식은 유동성이 매우 낮습니다최신 재무 보고서가 1년 이상 지났습니다.모든 위험 점검 보기SPR Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueCA$Current PriceN/A해당 없음내재 할인율Est. Revenue$PastFuture-59m775k2016201920222025202620282031Revenue CA$533.6kEarnings CA$78.3kAdvancedSet Fair ValueView all narrativesSproutly Canada Inc. 경쟁사CanadaBis CapitalSymbol: TSXV:CANBMarket cap: CA$2.1mDelivra Health BrandsSymbol: TSXV:DHBMarket cap: CA$3.8mMountain Valley MD HoldingsSymbol: CNSX:MVMDMarket cap: CA$36.6mAvant BrandsSymbol: TSX:AVNTMarket cap: CA$8.9m가격 이력 및 성과Sproutly Canada 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가CA$052주 최고가CA$052주 최저가CA$0베타01개월 변동n/a3개월 변동n/a1년 변동n/a3년 변동n/a5년 변동n/aIPO 이후 변동n/a최근 뉴스 및 업데이트공시 • Sep 20Sproutly Canada Inc. (CNSX:SPR) executed a binding Letter of Intent to acquire Global assets of Apollon Formularies for CAD 7 million.Sproutly Canada Inc. (CNSX:SPR) executed a binding Letter of Intent to acquire Global assets of Apollon Formularies for CAD 7 million on September 12, 2023. After the successful completion of due diligence, Sproutly will acquire the assets of Apollon pursuant to an Asset Purchase Agreement. In exchange, Sproutly will issue to Apollon a sufficient number of Sproutly shares so that Apollon will own 49% of the enlarged shar capital of Sproutly, post-transaction. If the transaction takes place with the number of outstanding Sproutly shares as are currently in issue, and at an anticpated deemed price of CAD 0.02 (the price at which the trading of common shares of Sproutly was suspended), the effective valuation of the disposal of Apollon's assets will be CAD 7 million. The disposal of the assets will likely constitute a fundamental change to Apollon's business, and therefore an explanatory circular will be prepared and a general meeting called in due course, to obtain shareholder approval for the disposal.공시 • Sep 03Sproutly Canada Inc. announced that it has received CAD 0.1 million in fundingSproutly Canada Inc. announced a private placement of 6,666,666 units at a price of CAD 0.015 per unit for gross proceeds of CAD 100,000 on September 1, 2022. Each unit consisting of one common share and one non-transferable common share purchase warrant. Each warrant entitles the holder to acquire an additional common share at an exercise price of CAD 0.05 for a period of two years from the date of issue. All securities issued in connection with the private placement are subject to a four month and a day transfer restriction from the date of issuance. The private placement is subject to the approval of the Canadian Securities Exchange. The company paid finder's fees in the amount of CAD 8,000 through the issuance of 552,500 units on the same terms as described above.Reported Earnings • Jan 30Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: CA$0.003 loss per share (up from CA$0.004 loss in 3Q 2021). Revenue: CA$94.6k (up 166% from 3Q 2021). Net loss: CA$1.13m (loss narrowed 6.4% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 58% per year, which means it is significantly lagging earnings.Reported Earnings • Oct 31Second quarter 2022 earnings released: CA$0.001 loss per share (vs CA$0.007 loss in 2Q 2021)The company reported a decent second quarter result with reduced losses and improved control over expenses, although revenues were weaker. Second quarter 2022 results: Revenue: CA$109.6k (down 44% from 2Q 2021). Net loss: CA$310.2k (loss narrowed 82% from 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 58% per year, which means it is performing significantly worse than earnings.공시 • Aug 17Sproutly Canada Inc. (CNSX:SPR) acquired Primary Assets of CannaHive Inc.Sproutly Canada Inc. (CNSX:SPR) acquired Primary Assets of CannaHive Inc. on August 16, 2021. Sproutly Canada Inc. (CNSX:SPR) completed the acquisition of Primary Assets of CannaHive Inc. on August 16, 2021.Reported Earnings • Jul 20Full year 2021 earnings released: CA$0.061 loss per share (vs CA$0.30 loss in FY 2020)The company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2021 results: Revenue: CA$316.4k (down 66% from FY 2020). Net loss: CA$16.4m (loss narrowed 73% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has fallen by 55% per year, which means it is performing significantly worse than earnings.더 많은 업데이트 보기Recent updates공시 • Sep 20Sproutly Canada Inc. (CNSX:SPR) executed a binding Letter of Intent to acquire Global assets of Apollon Formularies for CAD 7 million.Sproutly Canada Inc. (CNSX:SPR) executed a binding Letter of Intent to acquire Global assets of Apollon Formularies for CAD 7 million on September 12, 2023. After the successful completion of due diligence, Sproutly will acquire the assets of Apollon pursuant to an Asset Purchase Agreement. In exchange, Sproutly will issue to Apollon a sufficient number of Sproutly shares so that Apollon will own 49% of the enlarged shar capital of Sproutly, post-transaction. If the transaction takes place with the number of outstanding Sproutly shares as are currently in issue, and at an anticpated deemed price of CAD 0.02 (the price at which the trading of common shares of Sproutly was suspended), the effective valuation of the disposal of Apollon's assets will be CAD 7 million. The disposal of the assets will likely constitute a fundamental change to Apollon's business, and therefore an explanatory circular will be prepared and a general meeting called in due course, to obtain shareholder approval for the disposal.공시 • Sep 03Sproutly Canada Inc. announced that it has received CAD 0.1 million in fundingSproutly Canada Inc. announced a private placement of 6,666,666 units at a price of CAD 0.015 per unit for gross proceeds of CAD 100,000 on September 1, 2022. Each unit consisting of one common share and one non-transferable common share purchase warrant. Each warrant entitles the holder to acquire an additional common share at an exercise price of CAD 0.05 for a period of two years from the date of issue. All securities issued in connection with the private placement are subject to a four month and a day transfer restriction from the date of issuance. The private placement is subject to the approval of the Canadian Securities Exchange. The company paid finder's fees in the amount of CAD 8,000 through the issuance of 552,500 units on the same terms as described above.Reported Earnings • Jan 30Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: CA$0.003 loss per share (up from CA$0.004 loss in 3Q 2021). Revenue: CA$94.6k (up 166% from 3Q 2021). Net loss: CA$1.13m (loss narrowed 6.4% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 58% per year, which means it is significantly lagging earnings.Reported Earnings • Oct 31Second quarter 2022 earnings released: CA$0.001 loss per share (vs CA$0.007 loss in 2Q 2021)The company reported a decent second quarter result with reduced losses and improved control over expenses, although revenues were weaker. Second quarter 2022 results: Revenue: CA$109.6k (down 44% from 2Q 2021). Net loss: CA$310.2k (loss narrowed 82% from 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 58% per year, which means it is performing significantly worse than earnings.공시 • Aug 17Sproutly Canada Inc. (CNSX:SPR) acquired Primary Assets of CannaHive Inc.Sproutly Canada Inc. (CNSX:SPR) acquired Primary Assets of CannaHive Inc. on August 16, 2021. Sproutly Canada Inc. (CNSX:SPR) completed the acquisition of Primary Assets of CannaHive Inc. on August 16, 2021.Reported Earnings • Jul 20Full year 2021 earnings released: CA$0.061 loss per share (vs CA$0.30 loss in FY 2020)The company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2021 results: Revenue: CA$316.4k (down 66% from FY 2020). Net loss: CA$16.4m (loss narrowed 73% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has fallen by 55% per year, which means it is performing significantly worse than earnings.공시 • May 08+ 1 more updateSproutly Canada, Inc. Completes the Formulation of Its Initial Beverage ProductsSproutly Canada Inc. announced it has completed the formulation of its initial beverage products and filed with Health Canada its NNCP notification related to cannabis-infused beverages utilizing cannabis extracts produced by the APP Technology. Sproutly's beverages deliver a predictable and rapid onset and offset of true to strain cannabis experiences that are not achieved by distillates and terpenes. The company's beverages are their second 2.0 product to be submitted, with the intended launch set for the third quarter of calendar 2021. The beverages are being launched under Sproutly's Caliber brand starting with the company's Lemon Z and Berry White strains to deliver a Sativa and an Indica experience, respectively. Each product will be available in both a single 2 ounce (60mL) bottle with whole plant extract that contains 5mg THC, and a single 8 ounce (237mL) bottle containing 10mg THC, the maximum allowed under Canada's Cannabis Act. The products will be sold under its Health Canada licensed subsidiary, Toronto Herbal Remedies Inc. ("THR") and leverage THR's current provincial supply agreements within Canada.공시 • Apr 16Sproutly Canada Inc. announced that it has received CAD 1.348302 million in fundingOn April 15, 2021, Sproutly Canada Inc. (CNSX:SPR) closed the transaction. The company issued 15,916,037 units for CAD 795,802 in its second and final tranche. The company issued a total of 26,966,037units for CAD 1,348,302 in the transaction. The transaction included participation from Arup Sen, Chief Executive Officer and director of the company through a company controlled by Sen participated for 3,000,000 units. The transaction is subject to the approval of Canadian Securities Exchange. The company will issuance of 450,000 units for CAD 22,500 to finders in the transaction.공시 • Mar 16Sproutly Canada Inc. announced a financing transactionSproutly Canada Inc. (CNSX:SPR) announced a private placement of units on March 15, 2021. Each unit consisting of one common share and one non-transferable common share purchase warrant. Each warrant entitles the holder to acquire an additional common share at an exercise price of CAD 0.07 for a period of two years from the date of issue. All securities issued in connection with the private placement are subject to a four month and a day transfer restriction from the date of issuance. The transaction is subject to the approval of the Canadian Securities Exchange. The company paid finder's fess of CAD 24,862.50 through issuance of 497,250 units. On the same date, the company issued 11,050,000 units at a price of CAD 0.05 for gross proceeds of CAD 552,500.Reported Earnings • Jan 31Third quarter 2021 earnings released: CA$0.004 loss per share (vs CA$0.007 loss in 3Q 2020)Third quarter 2021 results: Net loss: CA$1.21m (loss narrowed 16% from 3Q 2020).공시 • Jan 12Sproutly Enters into LOI with Cannahive IncSproutly Canada Inc. has executed a Letter of Intent to enter into a commercial relationship with CannaHive Inc. The agreement will allow Sproutly to further expand its Cannabis 2.0 product offerings produced by the Company’s wholly-owned subsidiary, Toronto Herbal Remedies Inc. Sproutly will leverage CannaHive’s proprietary manufacturing and packaging equipment and intellectual property to produce cannabis dissolvable powder at THR’s licensed facility. This agreement follows closely on the heels of the LOI with Cannabis Manufacturer’s Guild Ltd. These relationships will provide synergies for the branding, commercialization, and distribution of a portfolio of cannabis products through THR’s existing agreements with multiple provinces in Canada.공시 • Dec 18Sproutly Canada Inc. Enters Into LOI With Cannabis Manufacturer’s Guild LtdSproutly Canada Inc. has executed a Letter of Intent (the “LOI”) to enter into a commercial relationship with Cannabis Manufacturer’s Guild Ltd. (“CMG”). The agreement will allow Sproutly to expand and diversify its flower and Cannabis 2.0 product offerings utilizing brands developed by CMG and its affiliates (the “Acquired Products”), through the Company’s wholly-owned subsidiary, Toronto Herbal Remedies Inc. (“THR”). Sproutly will leverage CMG’s expertise in branding, commercialization, and distribution of cannabis products for underserved categories in the Canadian market. The agreement allows Sproutly to sell the Acquired Products and facilitate potential business-to-business sales of Sproutly’s proprietary whole plant extracts to CMG’s network of Guild members.분석 기사 • Dec 02Would Sproutly Canada (CSE:SPR) Be Better Off With Less Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...공시 • Nov 17Sproutly Canada, Inc. Announcea the Addition of A Supply Agreement with the Ontario Cannabis StoreSproutly Canada Inc. announced the addition of a supply agreement with the Ontario Cannabis Store ("OCS"), the Company's 6th provincial supply agreement to date. This announcement comes on the heels of the Company's October 15th announcement regarding receipt of the sales license from Health Canada for Cannabis 2.0 products directly to provinces. The Company's wholly-owned subsidiary, Toronto Herbal Remedies ("THR"), has entered into a cannabis supply agreement with the province of Ontario (the "Supply Agreement") through the OCS. Ontario will be the 6th province in Canada to carry the Company's CALIBER branded products ("CALIBER"), following Saskatchewan, Manitoba, and British Columbia earlier this year as well as Alberta & New Brunswick in 2019. With the receipt of the license amendment that now permits the Company to sell Cannabis 2.0 products, the Company is in a position to offer its full line of products to the OCS. This includes Caliber Flower, Caliber Reserve Flower and upcoming Cannabis 2.0 products that will use the Company's proprietary APP Technology to offer consumers products that aim to deliver unique experiences of different cannabis strains arising from advances in cannabis genetics.공시 • Nov 10Sproutly Canada Inc. Announces Its Sixth Provincial Supply AgreementSproutly Canada Inc. announced the addition of a supply agreement with the Ontario Cannabis Store, the Company’s 6th provincial supply agreement to date. This announcement comes on the heels of the Company’s October 15th announcement regarding receipt of the sales license from Health Canada for Cannabis 2.0 products directly to provinces. The Company’s wholly-owned subsidiary, Toronto Herbal Remedies (“THR”), has entered into a cannabis supply agreement with the province of Ontario (the “Supply Agreement”) through the OCS. Ontario will be the 6th province in Canada to carry the Company’s CALIBER branded products ("CALIBER"), following Saskatchewan, Manitoba, and British Columbia earlier this year as well as Alberta & New Brunswick in 2019. With the receipt of the license amendment that now permits the Company to sell Cannabis 2.0 products, the Company is in a position to offer its full line of products to the OCS. This includes Caliber Flower, Caliber Reserve Flower and upcoming Cannabis 2.0 products that will use the Company’s proprietary APP Technology to offer consumers products that aim to deliver unique experiences of different cannabis strains arising from advances in cannabis genetics.공시 • Sep 07Sproutly Canada Inc. Auditor Raises 'Going Concern' DoubtSproutly Canada Inc. filed its Annual on Aug 31, 2020 for the period ending Feb 29, 2020. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.공시 • Aug 28Sproutly Canada Inc. announced that it has received CAD 0.96 million in funding from Infusion Biosciences Inc.Sproutly Canada Inc. (CNSX:SPR) announced a non-brokered private placement of 1,500,000 equity units at an issue price of 0.07 per equity unit for gross proceeds of CAD 105,000 and a secured convertible debenture for gross proceeds of CAD 855,000 and aggregate gross proceeds of CAD 960,000 on August 28, 2020. The debentures involved participation from returning investor Infusion Biosciences Inc. for CAD 855,000. The debentures carry an interest rate of 15% per annum and maturity date on or before October 24, 2020. The debenture will be convertible into debenture units a conversion price of CAD 0.07 per debt unit, subject to adjustment in accordance with the terms of the convertible debenture. Each debt unit will consist of one common share in the capital of the company and one common share purchase warrant, with each warrant entitling the investor to acquire one common share at an exercise price equal to CAD 0.08 for a period of two years from date of issuance. Each equity unit consists of one common share and one warrant, with each warrant entitling the holder to acquire one warrant share at an exercise price equal to CAD 0.08 for a period of two years from date of issuance. No finder's fees were paid in connection with the transaction. All securities issued in connection with the transaction will be subject to a four-month and one day hold period from their date of issue under applicable Canadian securities laws, in addition to such other restrictions as may apply under applicable securities laws of jurisdictions outside Canada.주주 수익률SPRCA PharmaceuticalsCA 시장7Dn/a1.3%1.5%1Yn/a45.3%33.7%전체 주주 수익률 보기수익률 대 산업: SPR의 Canadian Pharmaceuticals 산업 대비 성과를 판단하기에 데이터가 부족합니다.수익률 대 시장: SPR의 Canadian 시장 대비 성과를 판단하기에 데이터가 부족합니다.주가 변동성Is SPR's price volatile compared to industry and market?SPR volatilitySPR Average Weekly Movementn/aPharmaceuticals Industry Average Movement11.6%Market Average Movement10.2%10% most volatile stocks in CA Market18.0%10% least volatile stocks in CA Market3.9%안정적인 주가: SPR는 지난 3개월 동안 Canadian 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: Insufficient data to determine SPR의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트n/an/aArup Senwww.sproutly.ca는 수용성 대마초 용액과 바이오 천연 오일을 생산하여 캐나다의 음료 및 소모품 시장에 공급합니다. Caliber 브랜드로 제품을 제공합니다. 이 회사는 캐나다 밴쿠버에 본사를 두고 있습니다.더 보기Sproutly Canada Inc. 기초 지표 요약Sproutly Canada의 순이익과 매출은 시가총액과 어떻게 비교됩니까?SPR 기초 통계시가총액CA$7.58m순이익 (TTM)-CA$13.79m매출 (TTM)CA$533.55k0.0x주가매출비율(P/S)0.0x주가수익비율(P/E)SPR는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표SPR 손익계산서 (TTM)매출CA$533.55k매출원가CA$774.88k총이익-CA$241.33k기타 비용CA$13.54m순이익-CA$13.79m최근 보고된 실적Nov 30, 2021다음 실적 발표일해당 없음주당순이익(EPS)0총이익률0.00%순이익률0.00%부채/자본 비율0.0%SPR의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/07/06 08:31종가2024/04/08 00:00수익2021/11/30연간 수익2021/02/28데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Sproutly Canada Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Sep 20Sproutly Canada Inc. (CNSX:SPR) executed a binding Letter of Intent to acquire Global assets of Apollon Formularies for CAD 7 million.Sproutly Canada Inc. (CNSX:SPR) executed a binding Letter of Intent to acquire Global assets of Apollon Formularies for CAD 7 million on September 12, 2023. After the successful completion of due diligence, Sproutly will acquire the assets of Apollon pursuant to an Asset Purchase Agreement. In exchange, Sproutly will issue to Apollon a sufficient number of Sproutly shares so that Apollon will own 49% of the enlarged shar capital of Sproutly, post-transaction. If the transaction takes place with the number of outstanding Sproutly shares as are currently in issue, and at an anticpated deemed price of CAD 0.02 (the price at which the trading of common shares of Sproutly was suspended), the effective valuation of the disposal of Apollon's assets will be CAD 7 million. The disposal of the assets will likely constitute a fundamental change to Apollon's business, and therefore an explanatory circular will be prepared and a general meeting called in due course, to obtain shareholder approval for the disposal.
공시 • Sep 03Sproutly Canada Inc. announced that it has received CAD 0.1 million in fundingSproutly Canada Inc. announced a private placement of 6,666,666 units at a price of CAD 0.015 per unit for gross proceeds of CAD 100,000 on September 1, 2022. Each unit consisting of one common share and one non-transferable common share purchase warrant. Each warrant entitles the holder to acquire an additional common share at an exercise price of CAD 0.05 for a period of two years from the date of issue. All securities issued in connection with the private placement are subject to a four month and a day transfer restriction from the date of issuance. The private placement is subject to the approval of the Canadian Securities Exchange. The company paid finder's fees in the amount of CAD 8,000 through the issuance of 552,500 units on the same terms as described above.
Reported Earnings • Jan 30Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: CA$0.003 loss per share (up from CA$0.004 loss in 3Q 2021). Revenue: CA$94.6k (up 166% from 3Q 2021). Net loss: CA$1.13m (loss narrowed 6.4% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 58% per year, which means it is significantly lagging earnings.
Reported Earnings • Oct 31Second quarter 2022 earnings released: CA$0.001 loss per share (vs CA$0.007 loss in 2Q 2021)The company reported a decent second quarter result with reduced losses and improved control over expenses, although revenues were weaker. Second quarter 2022 results: Revenue: CA$109.6k (down 44% from 2Q 2021). Net loss: CA$310.2k (loss narrowed 82% from 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 58% per year, which means it is performing significantly worse than earnings.
공시 • Aug 17Sproutly Canada Inc. (CNSX:SPR) acquired Primary Assets of CannaHive Inc.Sproutly Canada Inc. (CNSX:SPR) acquired Primary Assets of CannaHive Inc. on August 16, 2021. Sproutly Canada Inc. (CNSX:SPR) completed the acquisition of Primary Assets of CannaHive Inc. on August 16, 2021.
Reported Earnings • Jul 20Full year 2021 earnings released: CA$0.061 loss per share (vs CA$0.30 loss in FY 2020)The company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2021 results: Revenue: CA$316.4k (down 66% from FY 2020). Net loss: CA$16.4m (loss narrowed 73% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has fallen by 55% per year, which means it is performing significantly worse than earnings.
공시 • Sep 20Sproutly Canada Inc. (CNSX:SPR) executed a binding Letter of Intent to acquire Global assets of Apollon Formularies for CAD 7 million.Sproutly Canada Inc. (CNSX:SPR) executed a binding Letter of Intent to acquire Global assets of Apollon Formularies for CAD 7 million on September 12, 2023. After the successful completion of due diligence, Sproutly will acquire the assets of Apollon pursuant to an Asset Purchase Agreement. In exchange, Sproutly will issue to Apollon a sufficient number of Sproutly shares so that Apollon will own 49% of the enlarged shar capital of Sproutly, post-transaction. If the transaction takes place with the number of outstanding Sproutly shares as are currently in issue, and at an anticpated deemed price of CAD 0.02 (the price at which the trading of common shares of Sproutly was suspended), the effective valuation of the disposal of Apollon's assets will be CAD 7 million. The disposal of the assets will likely constitute a fundamental change to Apollon's business, and therefore an explanatory circular will be prepared and a general meeting called in due course, to obtain shareholder approval for the disposal.
공시 • Sep 03Sproutly Canada Inc. announced that it has received CAD 0.1 million in fundingSproutly Canada Inc. announced a private placement of 6,666,666 units at a price of CAD 0.015 per unit for gross proceeds of CAD 100,000 on September 1, 2022. Each unit consisting of one common share and one non-transferable common share purchase warrant. Each warrant entitles the holder to acquire an additional common share at an exercise price of CAD 0.05 for a period of two years from the date of issue. All securities issued in connection with the private placement are subject to a four month and a day transfer restriction from the date of issuance. The private placement is subject to the approval of the Canadian Securities Exchange. The company paid finder's fees in the amount of CAD 8,000 through the issuance of 552,500 units on the same terms as described above.
Reported Earnings • Jan 30Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: CA$0.003 loss per share (up from CA$0.004 loss in 3Q 2021). Revenue: CA$94.6k (up 166% from 3Q 2021). Net loss: CA$1.13m (loss narrowed 6.4% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 58% per year, which means it is significantly lagging earnings.
Reported Earnings • Oct 31Second quarter 2022 earnings released: CA$0.001 loss per share (vs CA$0.007 loss in 2Q 2021)The company reported a decent second quarter result with reduced losses and improved control over expenses, although revenues were weaker. Second quarter 2022 results: Revenue: CA$109.6k (down 44% from 2Q 2021). Net loss: CA$310.2k (loss narrowed 82% from 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 58% per year, which means it is performing significantly worse than earnings.
공시 • Aug 17Sproutly Canada Inc. (CNSX:SPR) acquired Primary Assets of CannaHive Inc.Sproutly Canada Inc. (CNSX:SPR) acquired Primary Assets of CannaHive Inc. on August 16, 2021. Sproutly Canada Inc. (CNSX:SPR) completed the acquisition of Primary Assets of CannaHive Inc. on August 16, 2021.
Reported Earnings • Jul 20Full year 2021 earnings released: CA$0.061 loss per share (vs CA$0.30 loss in FY 2020)The company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2021 results: Revenue: CA$316.4k (down 66% from FY 2020). Net loss: CA$16.4m (loss narrowed 73% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has fallen by 55% per year, which means it is performing significantly worse than earnings.
공시 • May 08+ 1 more updateSproutly Canada, Inc. Completes the Formulation of Its Initial Beverage ProductsSproutly Canada Inc. announced it has completed the formulation of its initial beverage products and filed with Health Canada its NNCP notification related to cannabis-infused beverages utilizing cannabis extracts produced by the APP Technology. Sproutly's beverages deliver a predictable and rapid onset and offset of true to strain cannabis experiences that are not achieved by distillates and terpenes. The company's beverages are their second 2.0 product to be submitted, with the intended launch set for the third quarter of calendar 2021. The beverages are being launched under Sproutly's Caliber brand starting with the company's Lemon Z and Berry White strains to deliver a Sativa and an Indica experience, respectively. Each product will be available in both a single 2 ounce (60mL) bottle with whole plant extract that contains 5mg THC, and a single 8 ounce (237mL) bottle containing 10mg THC, the maximum allowed under Canada's Cannabis Act. The products will be sold under its Health Canada licensed subsidiary, Toronto Herbal Remedies Inc. ("THR") and leverage THR's current provincial supply agreements within Canada.
공시 • Apr 16Sproutly Canada Inc. announced that it has received CAD 1.348302 million in fundingOn April 15, 2021, Sproutly Canada Inc. (CNSX:SPR) closed the transaction. The company issued 15,916,037 units for CAD 795,802 in its second and final tranche. The company issued a total of 26,966,037units for CAD 1,348,302 in the transaction. The transaction included participation from Arup Sen, Chief Executive Officer and director of the company through a company controlled by Sen participated for 3,000,000 units. The transaction is subject to the approval of Canadian Securities Exchange. The company will issuance of 450,000 units for CAD 22,500 to finders in the transaction.
공시 • Mar 16Sproutly Canada Inc. announced a financing transactionSproutly Canada Inc. (CNSX:SPR) announced a private placement of units on March 15, 2021. Each unit consisting of one common share and one non-transferable common share purchase warrant. Each warrant entitles the holder to acquire an additional common share at an exercise price of CAD 0.07 for a period of two years from the date of issue. All securities issued in connection with the private placement are subject to a four month and a day transfer restriction from the date of issuance. The transaction is subject to the approval of the Canadian Securities Exchange. The company paid finder's fess of CAD 24,862.50 through issuance of 497,250 units. On the same date, the company issued 11,050,000 units at a price of CAD 0.05 for gross proceeds of CAD 552,500.
Reported Earnings • Jan 31Third quarter 2021 earnings released: CA$0.004 loss per share (vs CA$0.007 loss in 3Q 2020)Third quarter 2021 results: Net loss: CA$1.21m (loss narrowed 16% from 3Q 2020).
공시 • Jan 12Sproutly Enters into LOI with Cannahive IncSproutly Canada Inc. has executed a Letter of Intent to enter into a commercial relationship with CannaHive Inc. The agreement will allow Sproutly to further expand its Cannabis 2.0 product offerings produced by the Company’s wholly-owned subsidiary, Toronto Herbal Remedies Inc. Sproutly will leverage CannaHive’s proprietary manufacturing and packaging equipment and intellectual property to produce cannabis dissolvable powder at THR’s licensed facility. This agreement follows closely on the heels of the LOI with Cannabis Manufacturer’s Guild Ltd. These relationships will provide synergies for the branding, commercialization, and distribution of a portfolio of cannabis products through THR’s existing agreements with multiple provinces in Canada.
공시 • Dec 18Sproutly Canada Inc. Enters Into LOI With Cannabis Manufacturer’s Guild LtdSproutly Canada Inc. has executed a Letter of Intent (the “LOI”) to enter into a commercial relationship with Cannabis Manufacturer’s Guild Ltd. (“CMG”). The agreement will allow Sproutly to expand and diversify its flower and Cannabis 2.0 product offerings utilizing brands developed by CMG and its affiliates (the “Acquired Products”), through the Company’s wholly-owned subsidiary, Toronto Herbal Remedies Inc. (“THR”). Sproutly will leverage CMG’s expertise in branding, commercialization, and distribution of cannabis products for underserved categories in the Canadian market. The agreement allows Sproutly to sell the Acquired Products and facilitate potential business-to-business sales of Sproutly’s proprietary whole plant extracts to CMG’s network of Guild members.
분석 기사 • Dec 02Would Sproutly Canada (CSE:SPR) Be Better Off With Less Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
공시 • Nov 17Sproutly Canada, Inc. Announcea the Addition of A Supply Agreement with the Ontario Cannabis StoreSproutly Canada Inc. announced the addition of a supply agreement with the Ontario Cannabis Store ("OCS"), the Company's 6th provincial supply agreement to date. This announcement comes on the heels of the Company's October 15th announcement regarding receipt of the sales license from Health Canada for Cannabis 2.0 products directly to provinces. The Company's wholly-owned subsidiary, Toronto Herbal Remedies ("THR"), has entered into a cannabis supply agreement with the province of Ontario (the "Supply Agreement") through the OCS. Ontario will be the 6th province in Canada to carry the Company's CALIBER branded products ("CALIBER"), following Saskatchewan, Manitoba, and British Columbia earlier this year as well as Alberta & New Brunswick in 2019. With the receipt of the license amendment that now permits the Company to sell Cannabis 2.0 products, the Company is in a position to offer its full line of products to the OCS. This includes Caliber Flower, Caliber Reserve Flower and upcoming Cannabis 2.0 products that will use the Company's proprietary APP Technology to offer consumers products that aim to deliver unique experiences of different cannabis strains arising from advances in cannabis genetics.
공시 • Nov 10Sproutly Canada Inc. Announces Its Sixth Provincial Supply AgreementSproutly Canada Inc. announced the addition of a supply agreement with the Ontario Cannabis Store, the Company’s 6th provincial supply agreement to date. This announcement comes on the heels of the Company’s October 15th announcement regarding receipt of the sales license from Health Canada for Cannabis 2.0 products directly to provinces. The Company’s wholly-owned subsidiary, Toronto Herbal Remedies (“THR”), has entered into a cannabis supply agreement with the province of Ontario (the “Supply Agreement”) through the OCS. Ontario will be the 6th province in Canada to carry the Company’s CALIBER branded products ("CALIBER"), following Saskatchewan, Manitoba, and British Columbia earlier this year as well as Alberta & New Brunswick in 2019. With the receipt of the license amendment that now permits the Company to sell Cannabis 2.0 products, the Company is in a position to offer its full line of products to the OCS. This includes Caliber Flower, Caliber Reserve Flower and upcoming Cannabis 2.0 products that will use the Company’s proprietary APP Technology to offer consumers products that aim to deliver unique experiences of different cannabis strains arising from advances in cannabis genetics.
공시 • Sep 07Sproutly Canada Inc. Auditor Raises 'Going Concern' DoubtSproutly Canada Inc. filed its Annual on Aug 31, 2020 for the period ending Feb 29, 2020. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
공시 • Aug 28Sproutly Canada Inc. announced that it has received CAD 0.96 million in funding from Infusion Biosciences Inc.Sproutly Canada Inc. (CNSX:SPR) announced a non-brokered private placement of 1,500,000 equity units at an issue price of 0.07 per equity unit for gross proceeds of CAD 105,000 and a secured convertible debenture for gross proceeds of CAD 855,000 and aggregate gross proceeds of CAD 960,000 on August 28, 2020. The debentures involved participation from returning investor Infusion Biosciences Inc. for CAD 855,000. The debentures carry an interest rate of 15% per annum and maturity date on or before October 24, 2020. The debenture will be convertible into debenture units a conversion price of CAD 0.07 per debt unit, subject to adjustment in accordance with the terms of the convertible debenture. Each debt unit will consist of one common share in the capital of the company and one common share purchase warrant, with each warrant entitling the investor to acquire one common share at an exercise price equal to CAD 0.08 for a period of two years from date of issuance. Each equity unit consists of one common share and one warrant, with each warrant entitling the holder to acquire one warrant share at an exercise price equal to CAD 0.08 for a period of two years from date of issuance. No finder's fees were paid in connection with the transaction. All securities issued in connection with the transaction will be subject to a four-month and one day hold period from their date of issue under applicable Canadian securities laws, in addition to such other restrictions as may apply under applicable securities laws of jurisdictions outside Canada.
